IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 180 filers reported holding IMPAX LABORATORIES INC in Q1 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $2,000 | -99.3% | 166 | -99.3% | 0.00% | -100.0% |
| Q4 2016 | $299,000 | -95.2% | 22,630 | -91.5% | 0.00% | -96.8% |
| Q3 2016 | $6,275,000 | +76.2% | 264,783 | +114.3% | 0.03% | +72.2% |
| Q2 2016 | $3,561,000 | +118600.0% | 123,559 | +123459.0% | 0.02% | – |
| Q1 2016 | $3,000 | -99.8% | 100 | -99.9% | 0.00% | -100.0% |
| Q3 2014 | $1,607,000 | -86.3% | 67,790 | -82.7% | 0.01% | -86.0% |
| Q2 2014 | $11,751,000 | +1309.0% | 391,907 | +1141.5% | 0.06% | +1325.0% |
| Q1 2014 | $834,000 | -75.5% | 31,566 | -76.7% | 0.00% | -78.9% |
| Q4 2013 | $3,399,000 | +3106.6% | 135,193 | +2507.9% | 0.02% | +1800.0% |
| Q3 2013 | $106,000 | – | 5,184 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 560,400 | $9,022,000 | 3.93% |
| NORTH TIDE CAPITAL, LLC | 1,000,000 | $16,100,000 | 3.58% |
| Sivik Global Healthcare LLC | 250,000 | $4,025,000 | 1.47% |
| MAVERICK CAPITAL LTD | 7,159,336 | $115,265,000 | 1.44% |
| SECTOR GAMMA AS | 589,311 | $9,488,000 | 1.38% |
| BRIDGER MANAGEMENT, LLC | 1,341,143 | $21,592,000 | 1.23% |
| Eos Focused Equity Management, L.P. | 48,714 | $784,000 | 0.89% |
| Bridge City Capital, LLC | 47,194 | $760,000 | 0.64% |
| Fosun International Ltd | 300,000 | $4,830,000 | 0.60% |
| Century Capital Management, LLC | 203,138 | $3,271,000 | 0.56% |